55.84
-0.87 (-1.53%)
| Previous Close | 56.71 |
| Open | 56.70 |
| Volume | 1,191,961 |
| Avg. Volume (3M) | 1,184,387 |
| Market Cap | 5,185,704,448 |
| Price / Earnings (Forward) | 13.99 |
| Price / Sales | 1.70 |
| Price / Book | 1.77 |
| 52 Weeks Range | |
| Earnings Date | 31 Oct 2024 - 4 Nov 2024 |
| Profit Margin | -0.17% |
| Operating Margin (TTM) | 17.93% |
| Diluted EPS (TTM) | -0.080 |
| Quarterly Revenue Growth (YOY) | 8.80% |
| Quarterly Earnings Growth (YOY) | 8.60% |
| Total Debt/Equity (MRQ) | 64.41% |
| Current Ratio (MRQ) | 1.18 |
| Operating Cash Flow (TTM) | 104.03 M |
| Levered Free Cash Flow (TTM) | -143.48 M |
| Return on Assets (TTM) | 6.13% |
| Return on Equity (TTM) | 0.13% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Care Facilities (US) | Bullish | Mixed |
| Medical Care Facilities (Global) | Bullish | Mixed | |
| Stock | Acadia Healthcare Company, Inc. | Bullish | Bearish |
Stockmoo Score
| Analyst Consensus | 5.0 |
| Insider Activity | NA |
| Price Volatility | 5.0 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | -2.5 |
| Average | 2.50 |
|
Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities in the United States, United Kingdom, and Puerto Rico. Acute inpatient psychiatric facilities and specialty treatment facilities contribute the vast majority of Acadia's revenue in the United States. The U.S. facilities receive the major proportion of payments from Medicaid, with the second-largest proportion from commercial payors. In the United Kingdom, the majority of Acadia's revenue comes from its healthcare facilities, and virtually all of the payment received is from the National Health Service. |
|
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Investment Style | Small Core |
| % Held by Insiders | 2.97% |
| % Held by Institutions | 105.66% |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 94.00 (RBC Capital, 68.34%) | Buy |
| Median | 83.00 (48.64%) | |
| Low | 75.00 (Deutsche Bank, 34.31%) | Hold |
| Average | 83.75 (49.98%) | |
| Total | 2 Buy, 2 Hold | |
| Avg. Price @ Call | 67.00 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Cantor Fitzgerald | 04 Oct 2024 | 90.00 (61.17%) | Hold | 55.80 |
| 01 Oct 2024 | 90.00 (61.17%) | Hold | 62.41 | |
| Barclays | 30 Sep 2024 | 76.00 (36.10%) | Buy | 63.41 |
| 01 Aug 2024 | 83.00 (48.64%) | Buy | 74.09 | |
| RBC Capital | 20 Sep 2024 | 94.00 (68.34%) | Buy | 76.40 |
| Deutsche Bank | 02 Aug 2024 | 75.00 (34.31%) | Hold | 72.37 |
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2024 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |